Evidence map›Paper›PMID 29772712›Full record

ArticleViruses2018

Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Keggin Polyoxometalate.

Xiaoli Wang, Jiao Wang, Wenmei Zhang, Boye Li, Ying Zhu, Qin Hu, Yishu Yang, Xiaoguang Zhang, Hong Yan, Yi Zeng

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Xiaoli WangCollege of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, China. wangxiaoli@bjut.edu.cn.
Jiao WangNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China. wangjiao1018@hotmail.com.
Wenmei ZhangCollege of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, China. zwm1436271046@sina.com.
Boye LiCollege of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, China. liboye1994@sina.com.ORCID 0000-0002-1923-4013
Ying ZhuCollege of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, China. zhuying19901101@163.com.
Qin HuCollege of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, China. hq07616@bjut.edu.cn.ORCID 0000-0003-1196-879X
Yishu YangCollege of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, China. yishu-y@bjut.edu.cn.
Xiaoguang ZhangNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China. xgzhang01@163.com.
Hong YanCollege of Life Science and Bioengineering, Beijing University of Technology, Beijing 100124, China. hongyan@bjut.edu.cn.
Yi ZengNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China. zengyicdc@sina.com.
Beijing University of Technology · CNNational Institute for Viral Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we report the anti-human immunodeficiency virus (HIV) potency and underlying mechanisms of a Keggin polyoxometalate (PT-1, K₆HPTi₂W

Indexed as

AnimalsAntiviral AgentsCD4 AntigensCells, CulturedCell SurvivalFlow CytometryHIV-1HIV Envelope Protein gp120HIV Envelope Protein gp41HumansMaleMicePeptide FragmentsProtein BindingSurface Plasmon ResonanceTitaniumAntiviral AgentsCD4 Antigensgp120 protein, Human immunodeficiency virus 1gp41 protein, Human immunodeficiency virus 1HIV Envelope Protein gp120HIV Envelope Protein gp41Peptide Fragmentspeptide N36TitaniumTungsten CompoundsCD4entry inhibitiongp41 NHRhuman immunodeficiency virus type 1Keggin polyoxometalate

Identifiers

PMID29772712
PMCPMC5977258
OpenAlexW2804948224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.